Autopsy report · NCT07449481

A Phase II Clinical Study of Utidelone and Bevacizumab With or Without Etoposide in Patients With Brain Metastases From Malignant Solid Tumors

“Following an evaluation by the investigator, the study has been terminated due to exceptional circumstances.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Tianjin Medical University Cancer Institute and Hospital

Sponsor type

University, hospital or other

Conditions

Malignant Solid Tumor; Brain Metastasis

Interventions

Utidelone; Bevacizumab

Participants

0

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.